• Partner solutions
    • Customers
    • Pharmacies
    • Wholesalers
    • Hospitals
    • Suppliers
    • Suppliers of medicine
    • Transport companies
  • About us
    • Our values
    • Our Contribution
    • Purpose
    • Whistleblowing
    • Corporate Social Responsibility
    • Commercial profile
    • Business model and market
    • Healthcare costs are rising
    • Our Strategy
    • Timeline
    • News and Stories
    • Press images
    • Financial Results
    • Management
    • Board of Directors
    • Executive Management Team
  • Career
    • Get on board
    • Life at Abacus
    • Meet the Team
    • Student Board
    • Jobs
  • English
    • Deutsch
    • Magyar
    • Suomi
    • Austria

Abacus MedicineAbout usCommercial profile

Business model and market

Abacus Medicine is a distributor of original prescription medicines. Our business model is based on the core principle of the free movement of goods in the EU’s single market.

Currency rates and the price setting of original manufactures often make exactly the same medicine available at different prices in different EU countries. This allows Abacus Medicine to purchase the medicine in a low-cost country and make a profit by reselling it in a high-cost country. This is generally known as parallel trade, parallel distribution or parallel import.

The total market for parallel trade of medicines in Europe amounts to approximately 5.4 billion euros. The most important country is Germany, which accounts for more than half the total market. Because healthcare systems and national reimbursement rules differ substantially from country to country, a deep knowledge of each individual market is a cornerstone in the success of Abacus Medicine.

Healthcare costs are rising

Graph of Healthcare spending as percentage of GDP in Europe, USA and Japan

We are living longer. Children born in Western Europe in 2017 have an average life expectancy of 79 years for males and 84 years for females. This is a lot higher than it used to be.

Since 1970, the average life expectancy of a citizen of Germany has risen 10.1 years and for people in Portugal 14.5 years. In other parts of the world, life expectancy has risen even more. (1)

Living longer, happy lives is obviously a cause for joy. But it comes at a cost: It is often very expensive. The proportion of elderly is growing in all EU-member states, and our changing demographics have sent healthcare costs soaring with seemingly no end in sight.

Already, we are beginning to see our societies straining to bear the burden. Hospitals are laying off staff to pay for expensive medicine, and money spent on healthcare cannot be spent on other things we might value – better schools, safer roads, or protecting the environment, for example.

When Abacus Medicine supplies medicines at a more affordable price, the result is significant savings for patients and public budgets. A number of studies (2) have shown that parallel imports of medicine create direct and indirect savings worth billions of euros annually.

Our strategy

Abacus Medicine is a market leader in the most expensive types of medicines, such as chemotherapies for cancer treatment or immunosuppressive drugs used in connection with organ transplants. Prices of 3,000 euros or more are standard for these medicines.

We pursue an ambitious growth strategy through selling many types of medicines in many different countries. We invest heavily in entering new markets and in increasing the number of medicines that we hold a license to sell. Most of our competitors focus on fewer and less expensive products in a few countries or even a single country.

Our presence in many different markets adds complexity to our business. To navigate this complexity we have developed advanced methods and IT systems for complex data analysis in real time. This creates an important competitive advantage, as it allows us to buy and sell in the right markets, operate efficiently in logistics and production, and reduce risk by limiting our stocks of expensive medicines.

This approach has been uniquely value-creating. Year after year, Abacus Medicine has reported strong, organic growth coupled with sound profitability above the industry average.

Today, you will find our offices and more than 750 people in several countries.

Aposave logo

Our sourcing network and proven growth platform in Parallel Trade also provides opportunities in the pharmaceutical services industry.

We conduct our business in pharmaceutical services under the brand name Aposave.

Timeline

Abacus Medicine is a young company that has come far in a short time. Browse through the main events of our journey below.

  • 2004

    Abacus Medicine is founded by father and son: John and Flemming Wagner

  • 2006

    First deliveries to Danish pharmacies and hospitals

  • 2009

    Abacus Medicine becomes the largest parallel importer of medicine to the Danish hospital network

  • 2010

    Beyond borders: Sweden becomes our first export market

  • 2012

    Abacus Medicine Hungary is established

    First deliveries to Germany

  • 2014

    First deliveries in the Netherlands

  • 2015

    First deliveries in the UK and in Austria

  • 2016

    Turnover exceeds 1 billion DKK

  • 2017

    First deliveries in France and Finland

    Acquisition of Aposave

  • 2018

     Production begins at new, second site in Alkmaar in the Netherlands

  • 2019

    Chr. Augustinus Fabrikker joins as strategic investor

  • 2020

    Acquisition of Pluripharm

    The Group reaches 1,000 employees

  • empty_end (MÅ IKKE SLETTES)

Contact

We are happy to help, so please get in touch. Below you will find our main offices, but we have people covering all of Europe.

ABACUS MEDICINE Headquarters
Global Sales, Supply Chain and Finance

Vesterbrogade 149
1620 Copenhagen V
Denmark

+45 70 22 02 12
info@abacusmedicine.com
ABACUS MEDICINE Austria
Austrian Sales and Customer Support

Wolfgang-Pauli-Gasse 5/1/1/6
A-1140 Wien
Österreich

+43 1 26 50 642
+43 1 26 50 642 99
meinservice@abacusmedicine.at
ABACUS MEDICINE Hungary
Production and Regulatory

Maglódi út 6
1106 Budapest
Hungary

+36 1 848 0700
+36 1 431 7335
ABACUS MEDICINE Berlin GmbH
German Sales and Customer support

Berliner Straße 8
D-16727 Velten
Deutschland

+49 (0) 302 555 77 48
+49 (0) 322 1122 682 027
dtp@abacusmedicine.com
ABACUS MEDICINE UK
UK Sales and Customer Support

Abbey House
282 Farnborough Road
Farnborough GU14 7NA
England

+44 20 3630 1343
info@abacusmedicine.com
ABACUS MEDICINE Finland
Finnish Sales and Customer Support

Orionintie 5
02200 Espoo
Finland

+358 9 4272 1465
bdfi@abacusmedicine.com
ABACUS MEDICINE France
French Sales and Customer Support

12/14 Rond-Point des Champs-Elysées
Paris 75008, France

+33 1 53 53 61 55
info@abacusmedicine.com
ABACUS MEDICINE Netherlands
Production and Quality Assurance

Diamantweg 4
1812 RC Alkmaar
Holland

+31 72 202 93 65
info@abacusmedicine.com

Follow us on LinkedIn

Sitemap
  • Partner solutions
    • Customers
      • Pharmacies
      • Wholesalers
      • Hospitals
    • Suppliers
      • Suppliers of medicine
      • Transport companies
  • About us
    • Our values
      • Our Contribution
      • Purpose
      • Whistleblowing
      • Corporate Social Responsibility
    • Commercial profile
      • Business model and market
      • Healthcare costs are rising
      • Our Strategy
      • Timeline
      • Business Ventures
    • News and Stories
      • Press images
    • Financial Results
    • Management
      • Board of Directors
      • Executive Leadership team
  • Career
    • Get on board
    • Life at Abacus
    • Meet the Team
    • Student Committee
    • Unsolicited applications
    • Jobs

© 2020 All Rights Reserved · ABACUS MEDICINE A/S · Vesterbrogade 149 · 1620 Copenhagen · Denmark · CVR: DK 28 ‍11 15 76 · PRIVACY AND COOKIE POLICY

x
We use cookies to give you the best user experience.AcceptRead more